Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Modulation of Hippocampal GABAergic Neurotransmission and Gephyrin Levels by Dihydromyricetin Improves Anxiety

Frontiers in Pharmacology(2020)10.3389/fphar.2020.01008Source: DataRank Database

Modulation of Hippocampal GABAergic Neurotransmission and Gephyrin Levels by Dihydromyricetin Improves Anxiety is a research paper published in Frontiers in Pharmacology (2020). On theSindex it has a DataRank of 0. It has been cited 19 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access19 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 2.60)OA: goldTopics (54)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Amy S. Shao ORCID,Yi Shen ORCID,Daryl L. Davies ORCID,Richard W. Olsen,Daniel P. Holschneider ORCID

Live enrichment

PubMed:32742262 PMC:PMC7364153 OpenAlex:https://openalex.org/W3041208611

National Institutes of Health

Grant: 2R42DA044788-02

Developing an efficient E-cigarette aerosol generation and exposure system for rodent models with aerosol characteristics equivalent to those inhaled by E-cigarette users

National Institutes of Health

Grant: 1R01HL135623-01

Maternal inhaled nicotine leads to aberrant development of hypertensive phenotype

American Foundation for Pharmaceutical Education

National Institutes of Health

FWCI

2.60

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2025

2026

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fphar.2020.01008/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fphar.2020.01008/pdf

publisherhttps://www.frontiersin.org/article/10.3389/fphar.2020.01008/full

journalhttps://doi.org/10.3389/fphar.2020.01008

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32742262

Fields of Study

Medicinal plant effects and applicationsBiological Activity of Diterpenoids and BiflavonoidsNatural product bioactivities and synthesis03 medical and health sciences0302 clinical medicine

Keywords

GephyrinNeurotransmissionHippocampal formationNeuroscienceAnxietyGABAergicModulation (music)ChemistryMedicineInhibitory postsynaptic potentialPsychologyInternal medicineGlycine receptorPhysicsPsychiatryReceptorBiochemistrySocial IsolationGabaarDihydromyricetin (Dhm)Mental Health (rcdc)dihydromyricetin570Mental Illness (rcdc)610RM1-950Brain Disorders (rcdc)Behavioral and Social Science2.1 Biological and endogenous factors32 Biomedical and Clinical Sciences (for-2020)Neurosciences (rcdc)3214 Pharmacology and Pharmaceutical Sciences (for-2020)Anxiety Disorders (rcdc)Pharmacology3 Good Health and Well Being (sdg)Biomedical and Clinical Sciences1115 Pharmacology and Pharmaceutical Sciences (for)GABA(A)RNeurosciencesPharmacology and Pharmaceutical Sciences2.1 Biological and endogenous factors (hrcs-rac)Anxiety DisordersMental IllnessBrain DisordersMental health (hrcs-hc)Mental HealthGood Health and Well BeingTherapeutics. PharmacologyBehavioral and Social Science (rcdc)

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being